Hello @zaidi675
I expect that ARB has current (trailing) earnings power to current market cap (about $1,500m, @ $18.9 per share) of about 3.1% or 3.2% (1). Or said differently, I think ARB is generating a trailing earnings yield of about 3.1% to 3.2%.
If I assign some value to franking credits (2) then I'm willing to say that ARB is currently generating a trailing somewhat grossed up earnings yield of about 3.4% to 3.6%.
With a 5 year view of growth, I expect a prospective earnings yield (similarly grossed up) of somewhere between 4.9% and 6.3% (3).
However, to assign no value to growth beyond year 5, for one of the greatest compounding machines in Australia, would be completely unfair. Without getting into a lot of detail, if I assume that each dollar retained by the company generates about $1.7 dollars of value, then I get that the total prospective return (including growth beyond year 5) is somewhere in the range 6.1% to 7.9%. I think of this as an expected return of about 7.0% (the mid point), with a somewhat pessimistic prospect of only 6.1%.
I don't think that's a terrible prospect, especially when I think about the capital gains tax I will incur when I sell (which I did when I sold a little about 6 weeks ago). But I also don't think it's a particularly enticing prospect.
I think if I could purchase ARB with an expected return of about 9.5% and a somewhat pessimistic return of at least 7.0%, then it would be an attractive prospect. To achieve this, according to my numbers, we would require a share price of about $13. This price would correspond with a trailing earnings yield of about 4.7% (a PE of about 21).
Cheers, Mars
(1): This is based on cash earnings (ie after expensing all R&D), and is based on earnings from sales only (which is how I usually like to think about earnings).
(2): Though not acknowledging the full face value of them. After all, who knows how much longer we will have the benefit of a full tax refund on imputation credits.
(3): This is what I call the present value of earnings, divided by the current market cap (hence a "yield"), with a 5 year view (so ignoring any growth beyond year 5). So it can be thought of as a prospective return which ignores the value of any growth beyond year 5.
- Forums
- ASX - By Stock
- Ann: Appendix 4E and Annual Report
ARB
arb corporation limited.
Add to My Watchlist
5.32%
!
$29.03

Hello @zaidi675 I expect that ARB has current (trailing)...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$29.03 |
Change
-1.630(5.32%) |
Mkt cap ! $2.402B |
Open | High | Low | Value | Volume |
$29.50 | $29.56 | $28.67 | $8.315M | 285.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 83 | $29.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$29.05 | 46 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 76 | 29.150 |
7 | 233 | 29.140 |
5 | 165 | 29.130 |
3 | 120 | 29.120 |
4 | 84 | 29.110 |
Price($) | Vol. | No. |
---|---|---|
29.190 | 12 | 2 |
29.200 | 80 | 2 |
29.210 | 47 | 2 |
29.220 | 202 | 3 |
29.230 | 149 | 4 |
Last trade - 14.03pm 04/04/2025 (20 minute delay) ? |
Featured News
ARB (ASX) Chart |
The Watchlist
AUK
AUMAKE LIMITED.
CEO Hai Yun Chen, Non-Executive Chairman Anthony Noble
CEO Hai Yun Chen
Non-Executive Chairman Anthony Noble
SPONSORED BY The Market Online